维生素D对结肠癌免疫微环境的影响:随机临床试验结果
该随机安慰剂对照试验在I-III期结肠癌患者术前给予大剂量维生素D3或安慰剂,评估其对肿瘤免疫微环境的影响。维生素D显著升高血浆25-羟基维生素D水平,增加CD3+CD8+记忆T细胞、减少调节性T细胞并改变TME空间结构。
要点
- 术前大剂量维生素D3可升高血浆25-羟基维生素D水平(P<0.001)
- 维生素D增加CD3+CD8+记忆T细胞(P=0.03)、减少CD3+CD4+FoxP3+调节性T细胞(P=0.02)
- 治疗后VDR表达总体下降(P=0.02),空间转录组以抑制性VDR活性为主
核心结论
- 术前大剂量维生素D补充具有免疫调节作用,可重塑结肠癌肿瘤微环境,值得进一步机制研究。
主要发现
- 维生素D显著升高血浆25-羟基维生素D水平(P<0.001)。
- 维生素D增加CD3+CD8+记忆T细胞(P=0.03),减少CD3+CD4+FoxP3+调节性T细胞(P=0.02)。
- 维生素D在空间上重组TME,使T细胞与肿瘤细胞更靠近。
- 治疗后VDR表达异质且总体下降(P=0.02),空间转录组主要反映抑制性VDR活性。
临床怎么用
- 结果支持维生素D的免疫调节作用,但尚不能据此改变临床实践,需进一步机制与临床研究验证。
局限性
- 空间免疫分析仅基于24例配对样本,样本量有限。
- VDR表达异质且治疗后总体下降,空间转录组以抑制性VDR活性为主,机制尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although vitamin D (VitD) exhibits anti-tumor activity in colorectal cancer (CRC) preclinically, its effects in the human tumor microenvironment (TME) remain unclear. We conducted a randomized, placebo-controlled trial of preoperative high-dose VitD supplementation in stage I-III colon cancer patients to assess its impact on the TME. Forty-two patients received either VitD3 (50,000 IU/day for 7 days, then 10,000 IU/day) or placebo before surgery. Spatial immune-profiling and assessment of VitD receptor (VDR) and CYP27B1 expression were performed on paired tumor samples from 24 patients. VitD significantly increased plasma 25-hydroxyvitamin D levels (P<0.001), increased CD3+CD8+ memory T cells (P=0.03), reduced CD3+CD4+FoxP3+ regulatory T cells (P=0.02) and spatially re-organized the TME, leading to greater T cell and tumor cell proximity. Post-treatment VDR expression was heterogeneous and decreased overall (P=0.02). Spatial transcriptomic profiling of post-treatment resections reflected predominantly repressive VDR activity. These findings support an immunomodulatory role for VitD, warranting further mechanistic investigation.
引用
- Dias Costa A, Kim S, Hong SC, et al. Impact of vitamin D on the colon cancer immune microenvironment: results of a randomized clinical trial of preoperative vitamin D supplementation in patients with stage I-III colon cancer. Cancer Discov. 2026. PMID: 42417469. doi:10.1158/2159-8290.CD-25-1574
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。